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Abstract
Clathrin mediated endocytosis (CME) is an ubiquitous cel-
lular pathway that regulates central aspects of cell physi-
ology such as nutrient uptake, modulation of signal trans-
duction, synaptic transmission and membrane turn-over.
Endocytic vesicle formation depends on the timed produc-
tion of specific phosphoinositides and their interactions with
various endocytic proteins. Recently, it has been found
that phosphatidylinositol-3,4-bisphosphate (PI(3, 4)P2) pro-
duced by the class II phosphatidylinositol 3-kinase C2α plays
a key role in the recruitment of the PX-BAR domain pro-
tein SNX9, which is proposed to play a role in the con-
striction of the endocytic vesicle neck [1]. Interestingly,
SNX9 and its close paralog SNX18 are not fully specific to
PI(3, 4)P2 but can also bind other phospholipids, in par-
ticular to PI(4, 5)P2, an abundant plasma membrane lipid
required for the recruitment of many endocytic proteins. In
order to understand the dynamical interplay between phos-
pholipids and endocytic proteins, we developed a compu-
tational model of the temporal changes in the population
of the phosphoinositide-associated endocytic proteins and
their spatial distribution at a clathrin-coated pit (CCP). The
model resolves single molecules in time and space, and in-
corporates the complex interplay of proteins and lipids, as
well as their movement within the CCP. We find that the
comparably small differences in lipid binding affinities of en-
docytic proteins are amplified by competition among them,
allowing for the selective enrichment of SNX9 at late stage
CCPs as a result of timed PI(3, 4)P2 production.
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Introduction
Clathrin mediated endocytosis (CME) is a key process by
which cells internalize surface proteins including nutrient
and signalling receptors, adhesion proteins, or ion channels.
CME can be divided into four steps, CCP nucleation at the
plasma membrane, CCP invagination, dynamin-mediated
scission of late stage CCPs and clathrin uncoating of the
free vesicle. While many key players and interactions of
this endocytic pathway have been studied intensively, we are
just starting to understand the spatiotemporal regulation of
CME. An important factor in CME are phosphoinositides
and their timed formation by specific kinases and phos-
phatases [2, 3, 4]. Phosphatidylinositol-4,5-bisphosphate
[PI(4, 5)P2] is known to play an important role in CME
by associating with CCP components such as adaptor pro-
tein AP-2 and membrane curvature inducing proteins in-
cluding epsins [5, 6]. Less is known about phosphoinositides
other than PI(4, 5)P2 and their potential roles in regulating
CME. The recent identification of PI3K C2α and its lipid
product phosphatidylinositol-3,4-bisphosphate (PI(3, 4)P2)
as regulators of CME suggests an interplay of two distinct
PI-bisphosphate species, PI(4, 5)P2 and PI(3, 4)P2, in driv-
ing CME [1]. Formation of PI(3, 4)P2 appears to be spa-
tiotemporally coupled to PI(4, 5)P2-mediated CCP assem-
bly as recruitment of PI3K C2α depends on clathrin, which
via early acting adaptors FCHo, AP-2, or CALM selec-
tively associates with PI(4, 5)P2-rich membrane sites. El-
evated levels of PI(3, 4)P2 might then facilitate the enrich-
ment of PI(3, 4)P2-binding effector proteins, most notably
SNX9 prior to dynamin-mediated endocytic vesicle fission.
A prediction from these findings is that SNX9 is recruited
to CCPs subsequent to PI3K C2α but preceding the burst
of dynamin 2 recruitment. TIRF microscopy analysis of the
timing of endocytic protein recruitment indeed revealed that
accumulation of mCherry-SNX9 was delayed by about 20 s
with respect to eGFP-PI3K C2α but clearly preceded the
arrival of the majority of dynamin 2 [1], consistent with a
prominent role for PI(3, 4)P2 in stabilizing SNX9 at endo-
cytic sites. This time course of SNX9 arrival at CCPs co-
incides with a critical phase of the endocytic process dur-
ing which extensive membrane remodelling must occur as a
narrow stalk is formed that becomes a substrate for mem-
brane fission by dynamin (and possibly other proteins such
as epsins[7]). SNX9, in spite of its apparent dependence on
PI(3, 4)P2 production by PI3K C2α did not display a strong
preference for PI(3, 4)P2 over PI(4, 5)P2 in vitro. Since dif-
ferent endocytic proteins may compete for the same popu-
lation of PIs in vivo, the protein-lipid population dynamics
may be complex and cannot be predicted easily based on
single binding affinity values.
In this study, we designed a theoretical reaction-diffusion
model with single-molecule resolution, in order to grasp this
complex interplay of proteins and lipids. Computer simula-
tions of this model can trace population changes and spatial
distribution of PI-binding proteins at CCPs depending on PI
concentration. The model is parametrized to have a steady
state with absolute protein copy numbers determined from
proteomic studies[8] and uses published lipid binding affini-
ties of the major PI-binding endocytic proteins[5, 9, 10, 11]
(see Methods and [1] for details).
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Methods
Single-particle reaction diffusion simulation
model
In order to model the distribution and diffusion of phospho-
lipids and endocytic proteins underneath the clathrin coat,
a single-particle reaction-diffusion model of a single CCP
was developed. Computer simulations of this model can
trace phospholipid-dependent population changes at CCPs
depending on PI concentration. The model is parametrized
to have a steady state with absolute protein copy numbers
determined from proteomic studies and uses published lipid
binding affinities of the major PI-binding endocytic proteins
(see Table S1). This model represents space in a coarse-
grained manner, such that it is not able to resolve fine details
such as protein crowding as nonuniform protein distributions
reliably, but is rather suited to efficiently calculate the time-
dependent population changes of proteins at the CCP. The
simulation space consists of a hexagonal grid of 217 discrete
simulation cells, representing a membrane patch of about
200 nm diameter (see Fig. 1a). In order to model a proto-
typical clathrin cage, a fixed arrangement of 54 intertwined
clathrin triskelia was mapped on the grid (Fig. 1a). Each
clathrin triskelion exposes three binding sites to clathrin-
binding endocytic proteins underneath (Fig. 1b). In the
simulation, the clathrin coat has the sole purpose of defin-
ing the positions of these binding sites. At any time, each
simulation cell maintains the following pieces of information:
• Copy number of PI(3, 4)P2 and PI(4, 5)P2 molecules
• Copy number of membrane-associated proteins for each
of the following proteins: SNX9, AP-2, FCHo2, CALM,
Epsin.
• Number of clathrin binding sites, and which proteins are
bound there, if any. Each protein copy in the simulation
maintains the following data:
• The number of PI(3, 4)P2 or PI(4, 5)P2 molecules
bound.
The simulation proceeds in discrete time steps of 0.01 ms.
In each time step, all lipid molecules and all membrane-
associated protein molecules can diffuse laterally, and can
undergo “reactions”, corresponding to binding or unbinding
events.
Diffusion:
Both phosphoinositides and membrane-associated proteins
can diffuse laterally. Since each single copy of phospho-
inositide and protein is represented as an explicit object,
diffusion corresponds to jump events of lipids or proteins
between neighboring simulation cells. The probability with
which a jump may be attempted within a simulation time
step is calculated from the diffusion constant, the simulation
cell surface area, and the time step duration. For lipids, all
jump attempts are executed. For proteins, the success of a
jump event depends on the size of the protein and the oc-
cupancy of the target simulation cell. In this way, crowding
effects are included in the model - proteins can only diffuse
to places where sufficient physical space is vacant. Proteins
do not diffuse while they are bound to clathrin. Any lipids
bound to a protein are also not considered for independent
diffusional jumps, but will always move together with the
associated protein.
Reactions:
Within each simulation cell, several types of binding or un-
binding reactions may occur between clathrin, the endocytic
proteins and phosphoinositides contained in the cell (Fig.
1c-e). Since the simulation proceeds by discrete time steps,
one reaction event of each type is considered per time step
and is executed with the probability p = 1-exp(-k dt), where
k is the rate and dt is the time step duration.
• Protein association: Endocytic proteins are recruited to
the membrane from a small section of the cytosol 20nm
above the membrane with a rate constant kon,membrane
(Table S1). The number of proteins available per sim-
ulation cell for such a recruitment attempt is fixed by
the bulk concentration (Table S1). A recruitment event
is only executed, if the protein size can still be accom-
modated on the target cell.
• Protein dissociation: Membrane-associated proteins
that are bound to neither phosphoinositide nor clathrin
are only associated with their intrinsic affinity. Such a
protein may dissociate with a dissociation rate defined
by the intrinsic microscopic binding affinity, Ka,mem,
(Table S1) and the binding rate. Upon dissociation, it
is then removed from the simulation cell. The cytoso-
lic population remains constant throughout the simula-
tion. Membrane-associated proteins that bind at least
one phosphoinositide or are bound to a clathrin binding
site are not considered for dissociation. Such proteins
must first loose their phosphoinositide and/or dissociate
from clathrin before being considered for dissociation.
• Lipid binding: Phosphoinositide binding sites of any
membrane-associated protein can bind free phospho-
inositides present in the same simulation cell with a
rate Kon,lipid (Table S1).
• Lipid unbinding: Each binding site associated with a
phosphoinositide can unbind this lipid with dissocia-
tion rates based on the binding rates and the affinities
Ka,lip45, Ka,lipweak45, Ka,lip34 and Ka,lipweak34 (Ta-
ble S1).
• Clathrin-Protein association: Proteins can bind to free
clathrin binding sites in the same simulation cell with a
rate Kon,clathrin (Table S1). Each clathrin binding site
can only associate with one protein at a time. The pro-
tein remains in the same simulation cell but is removed
from the freely diffusing pool.
• Clathrin-Protein dissociation: Proteins associated to
clathrin binding sites can dissociate with a rate accord-
ing to the binding rate and the affinity Ka,clathrin (Ta-
ble S1). The protein remains in the same simulation
cell and is returned to the freely diffusing pool.
• Production of PI(3, 4)P2 by PI3K C2α: PI(3, 4)P2 is
produced by phosphorylation from the implicit pool of
PI(4)P. Since PI3K C2α is associated with clathrin ter-
minal domains, the reaction is conducted at clathrin
binding sites with a rate kkinase (Table S1) whose value
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depends on the simulation parameter set used. Every
such reaction event increments the local PI(3, 4)P2 lipid
count by one. The production of PI(3, 4)P2 is only
started after a simulation time of 10 s.
• Depletion of PI(4, 5)P2 by phosphatases: In some simu-
lation parameter settings, we are considering the action
of phosphatases that deplete the PI(4, 5)P2 pool with a
rate of kphosphatase (Table S1) at every clathrin binding
site.
All reactions are described by a on- and an off-rate. Since
no sufficient experimental data was available to define all
these rates, we extracted the binding affinities (or dissoci-
ation constants) from experimental data, and then set the
absolute value of kon arbitrarily. The effect of this arbitrary
choice is that the kinetics, i.e. the speed at which equilibria
or steady states are reached in our simulation is not pre-
dictive - in reality the equilibrium protein population could
be reached faster or slower than in our simulations after the
change of the lipid concentration. However, the equilibrium
state itself, i.e. the number of membrane-associated proteins
of any type for each given lipid concentration is well-defined
based on experimentally-determined parameters and may be
used to draw conclusions.
Simulation setup and basic parameters
An overview of all parameters used in the reference param-
eter set can be found in Table S1. The set is based on
the model of a CCP having a diameter of about 100-150
nm and projected on a two-dimensional plane. The CCP
is simulated on a hexagonal simulation area of about 200
nm diameter, discretized into 217 hexagonal simulation cells
(see Fig. 1a), each having a radius of about 9.25 nm and a
surface area of 222.5 nm2, yielding a total surface area of
0.064 µm2. The model includes a regular hexagonal coat
of 54 clathrin molecules, giving rise to a lattice of 162 N-
terminal binding domains. These terminal binding domains
are associated with specific simulation cells - such that a
given simulation cell may have none, one or two terminal
domains. We simulate the dynamics for a total time of 20s,
in discrete time steps of 10 µs duration each. The simulation
starts with a concentration of 15,000 PI(4, 5)P2 phospho-
lipids per µm2, uniformly distributed over the simulation
area, resulting in 3 lipid molecules per cell. In the refer-
ence parameter set, the PI(4, 5)P2 concentration remains
constant over the simulation time. The scheme is different
for PI(3, 4)P2 : Here the simulation starts with zero lipids.
After 10s PI(3, 4)P2 is produced with a rate that elevates
the PI(3, 4)P2 concentration within 5 s to the same level
as the PI(4, 5)P2 concentration, consistent with expected
turnover numbers of PI3Ks[12] and the copy number[8] and
lifetime [1] of PI3K C2α at CCPs. PI(3, 4)P2 lipids are only
produced at clathrin terminal domains, because PI3K C2α
binds clathrin at this site[13].
Diffusion is modelled as a jump process between the grid
cells, depending on the molecule’s diffusion constant and
the area of grid cells of 222.5 nm2. For phospholipid diffu-
sion, the experimental value of 3 µm2s−1[14] was employed
for both PI(4, 5)P2 and PI(3, 4)P2, yielding a jump rate of
13482.1 s−1. For proteins, it is considered that diffusion in
the cytosol is much faster than lateral membrane diffusion.
Thus, the lateral diffusion constant of membrane-associated
proteins is determined by the diffusion of the bound phos-
phoinositides, here taken to be the lipid diffusion constant,
divided by the number of binding sites of the protein. This
calculation assumes that the lipids are sufficiently uncou-
pled such that their Brownian motion can be assumed to
be uncorrelated a priori, but are a posteriori coupled be-
cause the protein has to move as a single unit. Whenever it
was attempted to move a protein into a target cell (either
through diffusion, or through binding to the membrane from
the cytosol—see below), availability of sufficient space was
tested. The probability with which such a move would be
accepted was set to account for the actual space left in that
particular cell. For example, if a cell can take four globu-
lar proteins of a certain size, and three are already residing
inside the cell, the probability to successfully place a fourth
one is very low because it is unlikely that the space at the
randomly chosen insertion point is completely free of other
particles causing overlaps. We have thus computed place-
ment probabilities for proteins of different sizes, depending
on the space already allocated on the target cell, and fit-
ted this placement probability with the sigmoidal function
(1+exp(ar+b))−1 with r being the fraction of the simulation
cell area already occupied, and a and b being fitting parame-
ters (AP-2: a=18.8, b=-2.7; SNX9 & FCHo2: a=13, b=-2.8;
Calm & Epsin: a=9.3, b=-3.1). Protein-membrane associa-
tion parameters were computed based on published liposome
binding experiments. In these experiments, molecules in the
solution bind to a membrane and eventually bind different
kind of lipids. With the model we derived in the section “Pa-
rameterisation of the protein binding model” (see below),
we could differentiate between the two different processes
of membrane binding and lipid binding and could use them
separately in our microscopic model.
For all proteins but CALM, we assumed the macroscopic
KD of 7.6 µM of AP-2 for binding to PI(4, 5)P2[11]. For
CALM, we used 5.8 µM [9]. In our binding model, we as-
sumed CALM and epsin to have one binding site, FCHo2
and SNX9 to have two equal binding sites, and AP-2 to
have two strong and two weak binding sites[11]. The on-
rate of lipid binding was set to 10000 s−1. The cytosolic
protein concentrations were set such that the protein num-
bers found under the clathrin coat in the steady state before
the PI(3, 4)P2 increase matched the copy number of pro-
teins found in CCVs, as described in a recent quantitative
proteomic study[8]. Several other parameters (e.g. abso-
lute values of rates) are free parameters that do not affect
the steady states, provided that the parameters above are
chosen as described (table S1). In order to show that the
results of the simulation are robust with respect to parame-
ter changes, the values of important parameters were varied,
yielding a total of 270 different parameter sets that were all
tested as to whether they yielded the same qualitative re-
sults. The results of this parameter sampling are reported
in table S2 and Figure 3.
Parametrization of the protein-lipid binding
model
We describe how experimentally-measured lipid binding
affinities of endocytic proteins are transformed into their re-
spective microscopic simulation parameters. The membrane
3
Figure 1: Illustration of the single-particle reaction-diffusion model of a CCP. a) Hexagonal simulation grid. The large
green hexagon enscribes the area simulated, consisting of 217 simulation cells (small blue hexagons). The yellow and blue
structures represent 54 clathrin triskelia, with clathrin hubs shown as larger circles and binding sites shown as smaller
circles. The shaded gray area is considered to be the area underneath the clathrin coat. b) Detailed view of two nearby
clathrin triskelia (blue and yellow). The central sphere represents the hub of the clathrin triskelion, the terminal spheres
represent the clathrin binding sites available to endocytic proteins in the same simulation cell. c) Summary of the reaction
and binding processes occuring in simulation cells. d,e) Sketch of binding model for proteins with one/two phospholipid
binding sites. Symbols: d: dissolved protein; O: membrane bound protein, no lipid bound; X membrane bound protein,
one lipid bound; XO: membrane bound protein, lipid in left one of two binding sites; OX: membrane bound protein, lipid
in right one of two binding sites; XX: membrane bound protein, lipids in both of two binding sites; kmb: protein-membrane
binding rate; kub: protein-membrane unbinding rate; klb: protein-lipid binding rate; klu: protein-lipid unbinding rate. See
Methods section and Table S1 for further details about the model and its parameterization.
dissociation constant of proteins is defined by:
KD =
[Protein][Lipid]
[Complex]
where [Protein] is the volume concentration of the solvated
protein (e.g. measured as mole per litre), [Complex] is the
surface concentration of all proteins that are associated to
the membrane (either stably or transiently), and [Lipid] is
the surface concentration of lipids (e.g. measured in particles
per nm2). KD is an experimentally-measurable dissociation
constant. When the lipid and complex concentrations are
measured in the same unit, KD will have the same unit as
the protein concentration (e.g. mole per litre).
In order to convert the macroscopic entity KD into micro-
scopic simulation parameters, we must specify the dynamical
model that the simulation uses to represent protein binding
and dissociation events. Consider Fig. 1 c)-e) as an illustra-
tion of the binding dynamics. We consider a simulation cell
which is a membrane patch with area Acell. A hypotheti-
cal column of cytosol with height h is considered, yielding a
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simulation cell volume Vcell (h and thus Vcell can be chosen
arbitrarily - they are just needed as intermediate quantities
for the calculation). The volume concentration of protein is
thus given by:
[Protein] =
nd
Vcell
where nd is the average copy number of solvated proteins
considered in the simulation cell volume. We use the con-
vention that all lipid and associated protein concentrations
are measured in particle numbers per simulation cell area.
Thus,
[Lipid] = nlipid
is the number of lipids per surface area Acell. As shown in
Fig. 1 e), proteins can associate from the cytosol to state O,
in which no phospholipid is bound, and can dissociate from
state O to the cytosol. The fact that, depending on the set-
tings of the rates kmb and kmu, proteins can be membrane-
associated for some time even if no phospholipid is present
represents the intrinsic membrane affinity of endocytic pro-
teins. Usually, this intrinsic affinity is small and is controlled
by the ratio kmb/kmu. From the associated state O, proteins
may enter stably bound states (including at least one X),
where the identifyer X specifies which phospholipid binding
sites are filled. We use the convention that a protein cannot
dissociate from the membrane while at least one of the bind-
ing sites is filled with a phospholipid. This is based on the
reasoning that pulling a phospholipid out of the membrane
would be energetically extremely unfavorable. The mecha-
nism of dissociation in our model is thus that phospholipids
must first clear their binding sites, each with rate klu, before
being able to dissociate with rate kmu. The concentration
of membrane-associated proteins is the total number of pro-
teins in any lipid binding states on a surface Acell. For
proteins with a single binding site, this is:
[Complex] = nO + nX
where nO counts membrane-associated proteins with empty
binding sites and nX counts membrane-associated proteins
with filled binding sites. In proteins with two binding sites,
we have the configurations:
[Complex] = nOO + nXO + nOX + nXX
= n0 + 2n1 + n2
where nk counts the number of membrane-associated pro-
teins with k binding sites filled. Generally, when a protein
has N binding sites, we have
[Complex] =
N∑
k=0
(N
k
)
nk.
We write down the detailed balance equation for the protein
association/dissociation reactions:
ndkmb = n0kmu
nd
n0
=
kmu
kmb
=: Kd,mem
where we have defined the microscopic intrinsic membrane
affinity Kd,mem. The detailed balance equation for the lipid
binding/unbinding reactions are:
nknlipidklb = nk+1klu
nlipid
nk
nk+1
=
klu
klb
=: Kd,lip
for all k = 0, ..., N−1, where we have defined the microscopic
intrinsic lipid affinity Kd,lip. Kd,lip varies depending on
the protein and the type of lipid (PI(3, 4)P2 or PI(4, 5)P2).
Combining all previous equations, we end up with the ex-
pression
N∑
k=0
(N
k
)( nlipid
Kd,lip
)k
=
Kd,mem nlipid
KD Vcell
(1)
This permits the following approach to parametrize the
binding model from experimental measurements of KD:
1. Define a simulation cell height h to be used in the sim-
ulations, arriving at a cell volume Vcell.
2. Define a microscopic intrinsic protein-membrane affinity
by setting Kd,mem.
3. Calculate Kd,lip by solving Eq. (1) using the experi-
mental concentration of nlipid and the measured value
of KD.
For proteins with one binding site (CALM, Epsin), Eq. (1)
has an explicit solution:
K
(1)
d,lip =
nlipid
nlipidKd,mem
KD,CalmVcell
− 1
.
For proteins with two equal binding sites (SNX9, FCHo2),
Eq. (1) has the following solution:
K
(2)
d,lip =
nlipid√
nlipidKd,mem
KDVcell
− 1
.
For AP-2, the situation is more complex. Experimentally,
there is evidence that AP-2 has four binding sites. However,
these are not equally strong but rather there are two con-
formations [11] associated with lipid binding affinities K+d,lip
andK−d,lip, respectively. Working out the lipid configuration
for this case eventually yields the equation:
1 + 2
nlipid
K+d,lip
+ 2
nlipid
K−d,lip
+ 2
(
nlipid
K+d,lip
)2
+ 2
(
nlipid
K−d,lip
)2
+8
n2lipid
K+d,lipK
−
d,lip
+ 10
n3lipid
(K+d,lip)
2K−d,lip
+ 10
n3lipid
K+d,lip (K
−
d,lip)
2
+ 20
n4lipid
(K+d,lip)
2 (K−d,lip)2
=
Kd,mem nlipid
KD Vcell
(2)
To solve this formula for K+d,lip and K
−
d,lip we have to use
additional information, compared to the equal binding site
model in Equation 1, since we have now one additional un-
known which renders our formula underdetermined without
additional experimental input. Fortunately, in the case of
AP-2, such additional input is available: The macroscopic
dissociation constant KD for AP-2 is known for the case
where all four binding sites are operational[11]. We will re-
fer here to that value by K++−−D . Additionally the value
K
++//
D is known, the dissociation constant for a mutant
where the two weak binding sites have been mutationally
inactivated[11]. Having these two constants, we now can
firstly use K++//D in Equation 1 based on two binding sites,
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which gives us a value for K+d,lip and can then secondly use
that value together with K++−−D in Equation 2 to end up
with a value for K−d,lip. The numerical values of the binding
model parameters used are given in Table S1.
Results
A representative set of parameters for protein and lipid con-
centrations, binding affinities, rates and diffusion constants,
was selected (Table S1) and the results are reported in Fig-
ure 2a. This data set uses an initially zero PI(3, 4)P2 con-
centration and a time-independent PI(4, 5)P2 concentration
of approximately 15,000 lipids per µm2as PI 5-kinases are
absent from assembled CCPs or coated vesicles[15]. The
time-independent PI(4, 5)P2 concentration is a conservative
assumption as several PI(4, 5)P2-specific phosphatases have
been shown to be present in endocytic CCPs[16, 17], poten-
tially resulting in progressive PI(4, 5)P2 hydrolysis.
With these lipid concentrations, the simulation reaches a
steady state with a strong population of PI(4, 5)P2 binders
such as AP-2, but only few SNX9 molecules associated
with CCP membranes (Fig. 2a, top). Based on the
experimentally-determined time course of PI3K C2α recruit-
ment to CCPs[1] we analysed the effects of increasing the
PI(3, 4)P2 concentration in the simulation with respect to
the concentration of the major endocytic PI binding proteins
underneath the clathrin coat. Strikingly and consistently,
SNX9 was the only endocytic protein which prominently en-
riched at CCPs concomitant with rising levels of PI(3, 4)P2,
whereas other endocytic PI-binding proteins such as AP-2,
FCHo, CALM, or epsin exhibited comparably minor changes
during the simulated time course of 20 s (Fig. 2a).
Strong PI(3, 4)P2-dependent SNX9 recruitment occurs
despite the conservative assumption that SNX9 binds to
PI(3, 4)P2 and PI(4, 5)P2 equally well (Table 1b). This in-
dicates that competition of different proteins for lipids plays
an important role. Other proteins strongly favor PI(4, 5)P2
binding over PI(3, 4)P2 binding, especially AP-2 and Epsin.
These proteins therefore win the competition for PI(4, 5)P2
lipids. This competition in turn acts as an amplification
of the PI(3, 4)P2 signal for SNX9 recruitment, which is the
only protein that can bind PI(3, 4)P2 sufficiently well to be
sensitive to this signal. This is indeed confirmed by control
simulations in the absence of competing endocytic proteins
resulting in a much weaker response of the SNX9 population
to increased PI(3, 4)P2 levels (see Fig. 3 bottom).
But why does SNX9 bind both PI(3, 4)P2 and PI(4, 5)P2
rather than being specific to PI(3, 4)P2 only? To explore
this we ran a control simulation in which SNX9 is assumed
to be PI(3, 4)P2-specific with no more than basal affinity for
PI(4, 5)P2. Fig. 2b shows that in this case, PI(3, 4)P2 re-
mains to serve as a strong signal for SNX9 recruitment, pro-
viding a large relative increase of the SNX9 population at the
CCP. However, the absolute copy number of SNX9 molecules
at the CCP are comparably low and remain insufficient for
assembly of a closed PX-BAR domain ring around the neck
of nascent late stage CCP. This observation provides a ra-
tional basis for its biochemical behaviour in lipid binding
assays [1]. Thus, it appears that PI(4, 5)P2 is important
for ensuring a basal concentration of SNX9 proteins. The
production of PI(3, 4)P2 in this scenario “tips the scale” to-
wards a selective amplification of SNX9 enrichment to reach
a number sufficient to drive the endocytic reaction forward.
To test the robustness of our results, we performed simu-
lations on varying PI concentrations and binding affinities,
yielding a total of 270 different parameter combinations. In
all combinations, increased PI(3, 4)P2 synthesis induced a
robust increase in the levels of SNX9 (Fig. 3, Table S2).
Discussion
The present results suggest a mechanistic interpretation of
the experimental results of Ref. [1] that is not apparent
from the biochemical data alone. Limited numbers of phos-
pholipids and lipid-binding proteins interact in a confined
space, giving rise to a dynamic and competitive system with
two surprising properties: (1) The activity of PI(3, 4)P2 is
amplified as a result of competition of proteins for different
types of lipids. (2) The limited specificity of SNX9, i.e. its
ability to bind to both PI(3, 4)P2 and PI(4, 5)P2 is impor-
tant for ensuring a sufficient total copy number of SNX9
molecules at a maturing CCP. The production of PI(3, 4)P2
can therefore be understood as a signal that tips the scales
of a system that is already poised for progression.
Important open questions remain. In particular it is un-
clear how SNX9 recruitment is controlled not only in time
but also in space and whether its enrichment at the CCP
neck is compatible with the presumed localization of PI3k
C2α and its lipid product PI(3, 4)P2. A SNX9-coated neck
may act as a molecule sling facilitating the constriction of
the vesicle neck [18, 19, 20, 21].
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Figure 2: Spatiotemporal regulation of CME by PI3K C2α-mediated PI(3, 4)P2 synthesis to recruit SNX9. a) Simulated
endocytic protein abundances underneath the clathrin coat of a 2D-projected CCP over time. Averaged protein copy
numbers (solid lines) ± SD (shaded vertical bars; n = 64 simulation runs) are shown (top). Ratio of protein copy numbers
normalized to those at time t = 10 s (middle). Concentration profile of PI(3, 4)P2 and PI(4, 5)P2 (bottom). Simulation
is divided in 3 phases: equilibration phase (0 s - 10 s): constant PI(4, 5)P2 (middle). Concentration profile of PI(3,4)P2
and PI(4,5)P2 (bottom). Simulation is divided in 3 phases: equilibration phase (0 s and zero PI(3, 4)P2 level; rising phase
(10 s-15 s): PI(3, 4)P2 is elevated to the level of PIP(4,5)P2; equilibration phase (15 s-20 s). SNX9 copy numbers are
selectively increased in response to PI(3, 4)P2 production to a value sufficient for formation of a ring around the CCP.
Relevance of PI(4, 5)P2 affinity for the recuitment of SNX9 is tested by a control simulation where SNX9 binds exclusively
PI(3, 4)P2 b). While SNX9 is strongly recruited to the membrane in both cases (a+b), the scenario in which SNX9 has
no PI(4, 5)P2 affinity (b), does not reach a sufficient SNX9 level to form a ring around the CCP. This can be explained by
the fact that PI(3, 4)P2 acts as an amplifier that multiplies the available SNX9 concentration with a certain factor, and
thus needs to start from a base level significantly above zero to reach a substantial target value. Thus, SNX9’s affinity to
PI(4, 5)P2 is essential.
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Figure 3: Sensitivity of CCP protein concentrations on the PI(3, 4)P2 lipids concentration. PI(3, 4)P2 is the main param-
eter for controlling the SNX9 concentration at the CCP, while other proteins exhibit little sensitivity on the PI(3, 4)P2
concentration. This can already be anticipated from Fig 2a, where it is seen that the SNX9 population essentially follows
the PI(3, 4)P2 increase, while the other proteins remain mostly at the same population. To demonstrate this dependency
more clearly, we have taken the simulated time traces of CCP protein numbers (e.g. Fig 2a), and, irrespective of the actual
time, plotted each point of the time trace in a coordinate system showing the PI(3, 4)P2 concentration on the x-axis and
the protein population on the y-axis. For visual clarity only data points from simulation times from t=10s to t=15s were
used as the PI(3, 4)P2 concentration was constant during other times. Row i shows absolute protein numbers, Rows ii
and iii show the relative increase of the protein number by dividing the absolute number by its value at [PI(3, 4)P2]=0.
The columns a,b,c,d correspond to different choices of simulation parameters, thereby summarizing the results of 270
simulation settings with different parameter combinations in a simple way. Four cases are distinguished here. Compared
to the reference parameter set (a), the other panels have parameter sets that are different from the reference set by one
setting. b) Protein-Clathrin affinity was set to zero. c) PI(4, 5)P2 affinity to SNX9 was set to zero; d) The PI(4, 5)P2
concentration is reduced to half its initial value rather than remaining constant; In all scenarios, a clear sensitivity of
SNX9 to the PI(3, 4)P2 concentration is seen, and the sensitivity of SNX9 population upon changes in PI(3, 4)P2 is always
stronger than the sensitivity of other proteins to PI(3, 4)P2. Other proteins show very little sensitive to PI(3, 4)P2. In row
iii, the relative change of SNX9 in the same conditions as in row ii (orange) is compared to a control simulation (black),
where only SNX9 and no other phospholipid-binding protein was in the system. It is seen that in cases a, b, and c, SNX9
shows a much stronger response to changes in PI(3, 4)P2 concentrations when other proteins are present than when they
are not present - the SNX9 number is approximately tripled rather than doubled. This indicates that PI(3, 4)P2 is not an
independent regulator of endocytosis, but that the regulation depends on the competing interactions of proteins with the
shared lipid pool.
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a) SNX9 AP-2 CALM FCHo2 Epsin
copy number1 7 54 54 33 21
footprint [nm²]2 34.25 84.5 8.46 83.6 9.8
# lipid bind. sites 2 4 (2s, 2w)3 1 2 1
KD,45[µMol] 7.6 (30.0)3,4 5.85
KD,34/KD,45 1.06 0.134 0.227 0.28 0.337
b) SNX9 AP-2 CALM FCHo2 Epsin
kdiff [s−1] 6741.57 3370.79 13483.1 6741.57 13483.1
conccytosol [1/Asim] 14.2 15.6 0.33 29.5 0.09
Ka,mem 0.11 5.19 5.2 0.11 4.03
Ka,lip45 3.32 0.21 9.98 3.32 9.98
Ka,lipweak45 0.0055
Ka,lip34 3.32 0.06 2.17 1.64 2.47
Ka,lipweak34 0.0574
Ka,clathrin 1.0 1.0 1.0 1.0 1.0
c) D [µm²/s] (experiment) kdiff [s−1] (model)
Phospholipids 39 13483.1
d) time [s] dt [µs] cellsize [nm²] cellradius [nm]
Global 20 10 222.3 9.25
kon,membrane [s−1] kon,lipid [s−1] kon,clathrin [s−1]
Global 100000 10000 10
e) kkinase [s−1] kphosphatase [s−1]
Clathrin N-terminal domain 0.8 (0.63)
Table 1: Reference parameter set for the reaction-diffusion simulation. a) Experimentally-determined parameters used for
the proteins simulated in the reaction-diffusion model, references are marked by superscripts and enlisted below. b) Protein-
specific parameters used in the reaction-diffusion simulation that were either derived from (a), or computed as described
in SI methods. c) Experimental and model parameters for the two phospholipids. d) Global simulation parameters. e)
Kinase and phosphatase turnover rates. The phosphatase was not active in the reference parameter set, but only in some
alternative parameter set considered in the parameter sampling (see Table S2). References: 1)[8], 2) PDB 2RAI, PDB
2xa7, PDB 1HFA, PDB 2V0o, PDB 1edu , 3) [11], 4) [22] , 5) [9], 6) [1], 7) [23], 8) [5], 9) [14]
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Parameter [SNX9] at t=10s [SNX9] at t=20s ∆SNX9 ∆ others
CA = 0 18.7 ± 14.2 82.4 ± 46.4 4.4 1.02 ± 0.14
CA = 1 19.4 ± 13.6 82.2 ± 45.0 4.2 1.04 ± 0.14
CA = 100 19.0 ± 13.1 81.9 ± 43.9 4.3 1.03 ± 0.14
PI(4, 5)P2 Affinity = 0 2.6 ± 2.9 57.2 ± 37.0 22.0 1.04 ± 0.15
PI(4, 5)P2 Affinity = 12 21.0 ± 3.3 87.9 ± 42.2 4.2 1.02 ± 0.14
PI(4, 5)P2 Affinity = 1 33.9 ± 2.3 102.3 ± 42.7 3.0 1.03 ± 0.13
no PI(4, 5)P2 depletion 19.2 ± 13.6 83.0 ± 45.1 4.3 1.15 ± 0.06
PI(4, 5)P2 depletion 19.0 ± 13.5 81.3 ± 44.7 4.3 0.92 ± 0.09
[PI(4, 5)P2] = 6.500/µm² 21.8 ± 12.0 88.9 ± 45.6 4.1 1.03 ± 0.11
[PI(4, 5)P2] = 13.000/µm² 17.2 ± 13.5 81.8 ± 47.1 4.8 1.02 ± 0.15
[PI(4, 5)P2] = 26.000/µm² 18.1 ± 14.8 75.6 ± 41.3 4.2 1.06 ± 0.15
[PI(3, 4)P2] = 12 [PI(4, 5)P2] 19.0 ± 13.6 40.5 ± 20.7 2.1 0.95 ± 0.13
[PI(3, 4)P2] = [PI(4, 5)P2] 19.1 ± 13.9 71.5 ± 20.8 3.7 1.03 ± 0.12
[PI(3, 4)P2] = 2 [PI(4, 5)P2] 19.0 ± 13.4 134.4 ± 26.1 7.1 1.11 ± 0.11
Table 2: Overview of the parameter sampling results. Several uncertain simulation parameters were sampled in order to
test whether our conclusions were robust with respect to parameter changes. For visual clarity, the 270 results are grouped
according to equal values in individual parameters, each such group is associated with a row in the table. To ensure
sufficient statistics, all 270 possible combinations of parameter values were simulated for 8 runs. The variation of the other
parameters is described in terms of the standard deviation over all samples reported as a second number in table entries
of columns 2,3, and 5. In the first column all sampled parameter values are shown. CA - The affinity of all proteins to
bind the N-terminal domain of clathrin. PI(4, 5)P2 Affinity - The affinity of SNX9 to PI(4, 5)P2 in relation to PI(3, 4)P2.
PI(4, 5)P2 depletion - the concentration of the lipid is decreased to half its starting value between t=10s and t=15s (or
not). [PI(4, 5)P2] - concentration of the lipid in the simulation. [PI(3, 4)P2 = x[PI(4, 5)P2] - the target concentration of
the lipid PI(3, 4)P2 in relation to the initial concentration of PI(4, 5)P2. The parameter values of the reference parameter
set are highlighted in green. The parameters were assessed based on the properties listed in the first row, columns 2-5. In
all scenarios, the concentration of SNX9 at t=10s (before addition of PI(3, 4)P2) was below the putative threshold of 40
to 50 copies required for ring formation (column 2). The only parameter with a significant influence on this quantity is
the PI(4, 5)P2 affinity of SNX9. On the other hand (column 3) the concentration of SNX9 at t=20s increases substantially
in all cases, and is usually well above 50. Higher PI(4, 5)P2 affinities and higher PI(3, 4)P2 concentrations have the most
prominent effect on the final SNX9 concentration. While a certain SNX9 affinity to PI(4, 5)P2 is needed to ensure a baseline
concentration of SNX9, the number of recruited SNX9 copies mainly depends on the amount of PI(3, 4)P2 produced (see
also Fig 3). Column 4 reports the relative increase of SNX9 when dividing the SNX9 copy number after PI(3, 4)P2
production by the SNX9 copy number before the increase of PI(3, 4)P2. Low PI(4, 5)P2 concentrations also results in a
high relative increase of SNX9, but are however starting from low initial SNX9 copy numbers and mostly do not reach
sufficient total SNX9 copy numbers. Consequently, both the ability to bind to PI(4, 5)P2 and sufficient PI(3, 4)P2 levels
are necessary to accumulate sufficient SNX9. Column 5 shows the relative change in copy numbers of the other proteins
between t=10s and t=20s.
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